Associations between Adiponectin and Two Different Cancers: Breast and Colon |
Gulcelik, Mehmet Ali
(General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health)
Colakoglu, Kadri (General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health) Dincer, Halil (General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health) Dogan, Lutfi (General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health) Yenidogan, Erdinc (General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health) Gulcelik, Nese Ersoz (Department of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University) |
1 | Weyer C, Funahashi T, Tanaka S, et al (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 86, 1930-5. DOI |
2 | Fukumoto J, Otake T, Tajima O, et al (2008). Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci, 99,781-6. DOI |
3 | Goktas S, Yilmaz MI, Caglar K, et al (2005). Prostate cancer and adiponectin. Urology, 65, 1168-72. DOI |
4 | Grossmann ME, Nkhata KJ, Mizuno NK, et al (2008). Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer, 29, 370-9. |
5 | Hu E, Liang P, Spiegelman BM (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 3, 10697-703. |
6 | Ishikawa M, Kitayama J, Kazama S, et al (2005). Plasma adiponectin and gastric cancer. Clin Cancer Res, 11, 466-7. |
7 | Kang JH, Yu BY, Youn DS (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci, 22, 117-21. DOI |
8 | Karaduman M, Bilici A, Ozet A, et al (2007). Tissue levels of adiponectin in breast cancer patients. Med Oncol, 24, 361-6. DOI |
9 | Kelesidis I, Kelesidis T, Mantzoros CS (2006). Adiponectin and cancer: a systematic review. Br J Cancer, 94, 1221-5. DOI |
10 | Kim AY, Lee YS, Kim KH, et al (2010). Adiponectin represses colon cancer cell proliferation via adipoR1- and -R2- mediated AMPK activation. Mol Endocrinol, 24, 1441-52. DOI |
11 | Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-278. DOI |
12 | Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89, 1102-7. DOI |
13 | Matsuzawa Y, Funahashi T, Nakamura T (1999). Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte derived bioactive substances. Ann N Y Acad Sci, 892, 146-54. DOI |
14 | Arditi JD, Venihaki M, Karalis KP, et al (2007). Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res, 39, 9-13. DOI |
15 | Arita Y, Kihara S, Ouchi N, et al (1999). Paradoxical decrease of an adipose specific protein, adiponectin in obesity. Biochem Biophys Res Commun, 257, 79-83. DOI |
16 | Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cellapoptosis. Proc Natl Acad Sci USA, 101, 2476-81. DOI |
17 | Chandran M, Phillips SA, Ciaraldi T, et al (2003). Adiponectin: more than just another fat cell hormone? Diab Care, 26, 2442-50. DOI |
18 | Chen DC, Chung YF, The YT, et al (2006). m Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14. DOI |
19 | Dal Maso L, Augustin LS, Karalis A, et al (2004). Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89, 1160-3. DOI |
20 | Dieudonne MN, Bussiere M, Dos Santos E, et al (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 345, 271-9. DOI |
21 | Fujisawa T, Endo H, Tomimoto A, et al (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 57, 1531-8. DOI |
22 | Sugiyama M, Takahashi H, Hosono K, et al (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/ mTOR pathway. Int J Oncol, 34, 339-44. |
23 | Wolk A, Gridley G, Svensson M, et al (2001). A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control, 12, 13-21. DOI |
24 | Yamauchi T, Kamon J, Ito Y, et al (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-9. DOI |
25 | Miyoshi Y, Funahashi T, Kihara S, et al (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9, 5699-704. |
26 | Okamoto Y, Kihara S, Ouchi N, et al (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 106, 2767-70. DOI |
27 | Otake S, Takeda H, Suzuki Y, et al (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11, 3642-6. DOI |
28 | Petridou E, Mantzoros C, Dessypris N, et al (2003). Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab, 88, 993-7. DOI |
29 | Schlienger JL, Luca F, Vinzio S, et al (2009). Obesity and cancer. Rev Med Interne, 30, 776-82. DOI |
30 | Takahata C, Miyoshi Y, Irahara N, et al (2007). Demonstration of Adiponectin Receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett, 250, 229-36. DOI |
31 | Tian YF, Chu CH, Wu MH, et al (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer, 14, 669-677. DOI |
32 | Tworoger SS, Eliassen AH, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92, 1510-6. DOI |
33 | Wei EK, Giovannucci E, Fuchs CS, et al (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94. DOI |